Correlation between antibiotic consumption and bacterial resistance as quality indicator of proper use of these drugs in inpatients

Vojnosanitetski Pregled

Volumn 66, Issue 4, 2009, Pages 307-312

  Velickovic Radovanovic, Radmila ^a,c   Petrović, Jasmina ^c   Kocić, Branislava ^a,b   Antić, Snežana ^b   Ranelović, Gordana ^a,b  

^a Medical Faculty   (Serbia)

^b Institute of Public Health   (Serbia)

^c Clinical Centre Nis   (Serbia)

Author keywords

Anti bacterial agents; Drug resistance, bacterial; Drug utilization; Quality control; Therapeutics

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; PENICILLIN G; PROCAINE PENICILLIN; ANTIINFECTIVE AGENT;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; CITROBACTER; DRUG USE; DRUG UTILIZATION; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; HOSPITAL BED; HOSPITAL PATIENT; HUMAN; KLEBSIELLA; LENGTH OF STAY; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SERBIA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; HUMANS;

EID: 66349084473     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/VSP0904307V     Document Type: Article

References (27)

1. Vlahović-Palcevski V, Morović M, Palcevski G, Betica-Radić L. Antimicrobial utilization and bacterial resistance at three different hospitals. Eur J Epidemiol 2001; 17(4): 375-383
2. Raymond DP, Pelletier SJ, Sawyer RG. Antibiotic utilization strategies to limit antimicrobial resistance. Semin Respir Crit Care Med 2002; 23(5): 497-501. (Pubitemid 35397219)
3. Willemsen I, Groenhuijzen A, Bogaers D, Stuurman A, van Keulen P, Kluytmans J. Appropriateness of antimicrobial therapy measured by repeated prevalence surveys. Antimicrob Agents Chemother 2007; 51(3): 864-867 (Pubitemid 46355268)
4. Ballow CH, Schentag JJ. Trends in antibiotic utilization and bacterial resistance. Report of the National Nosocomial Resistance Surveillance Group. Diagn Microbiol Infect Dis 1992; 15(2 Suppl): 37S-42S.
5. Urbánek K, Kolár M, Strojil J, Koukalová D, Cekanová L, Hejnar P. Utilization of fluoroquinolones and Escherichia coli resistance in urinary tract infection: inpatients and outpatients. Pharmacoepidemiol Drug Saf 2005; 14(10): 741-745 (Pubitemid 41489455)
6. Gulbinovic J, Myrbäck KE, Bytautieně J, Wettermark B, Struwe J, Bergman U. Marked differences in antibiotic use and resistance between university hospitals in Vilnius, Lithuania, and Huddinge, Sweden. Microb Drug Resist 2001; 7(4): 383-389
7. Yates RR. New intervention strategies for reducing antibiotic resistance. Chest 1999; 115(3 Suppl): 24S-27S. (Pubitemid 29133433)
8. Rice LB. Controlling antibiotic resistance in the ICU: different bacteria, different strategies. Cleve Clin J Med 2003; 70(9): 793-800. (Pubitemid 37161313)
9. Patterson JE, Hardin TC, Kelly CA, Garcia RC, Jorgensen JH. Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2000; 21(7): 455-458 (Pubitemid 30620213)
10. Kiivet RA, Dahl ML, Llerena A, Maimets M, Wettermark B, Berecz R. Antibiotic use in 3 European university hospitals. Scand J Infect Dis 1998; 30(3): 277-280 (Pubitemid 28461598)
11. Goryachkina K, Babak S, Burbello A, Wettemark B, Bergman U. Quality use of medicines: a new method of combining antibiotic consumption and sensitivity data-application in a Russian hospital. Pharmacoepidemiol Drug Saf 2008; 17(6): 636-644 (Pubitemid 351982770)
12. Goossens H, Ferech M, Vander Stichele R, Elseviers M. ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365(9459): 579-587 (Pubitemid 40247914)
13. WHO. ATC index with DDDs. World Health Organisation: World Health Organisation Collaborating Cente for Drug Statistics Methodology; 2003-2005. [accesed 2008 june 28]. Avalaible from: www.whocc.no/atcddd.
14. WHO Global Strategy for Containment of Antimicrobial Resistance. [accesed 2008 june 28]. Avalaible from: http://www.who.int/csr/drugresit/guidance/en
15. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A6. National Committee for Clinical Laboratory Standards; 2007.
16. Mochizuki T, Okamoto N, Yagishita T, Takuhiro K, Mashiko K, Ogawa F, et al.. Analysis of antimicrobial drug resistance of Staphylococcus aureus strains by WHONET 5: microbiology laboratory database software. J Nippon Med Sch 2004; 71(5): 345-351 (Pubitemid 39469730)
17. Hussein A Bataineh, Khalid M Alrashed.Resistant gram-negative bacilli and antibiotic consumption in Zarqa, Jordan. Pak J Med Sci 2007; 23 (1 ): 59-63.
18. Hermosilla Nájera L, Canut Blasco A, Ulibarrena Sanz M, Abasolo Osinaga E, Abecia Inchaurregui LC. Trends in antimicrobial utilization at a Spanish general hospital during a 5-year period. Pharmacoepidemiol Drug Saf 2003; 12(3): 243-247
19. Vlahović-Palcevski V, Dumpis U, Mitt P, Gulbinovic J, Struwe J, Palcevski G, et al. Benchmarking antimicrobial drug use at university hospitals in five European countries. Clin Microbiol Infect 2007; 13(3): 277-283
20. Veličković Radovanović R, Kocić B, Lilić R, Petrović J, Antić S. Antibiotic utilization and the development of bacterial resistance.Amstermad: International Proceedings Division; 2007. pp 153-156
21. Willemsen I, Groenhuijzen A, Bogaers D, Stuurman A, van Keulen P, Kluytmans J. Appropriateness of antimicrobial therapy measured by repeated prevalence surveys. Antimicrob Agents Chemother 2007; 51(3): 864-867 (Pubitemid 46355268)
22. Polk RE, Fox C, Mahoney A, Letcavage J, MacDougall C. Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis 2007; 44(5): 664-670 (Pubitemid 46272974)
23. MacDougall C, Powell JP, Johnson CK, Edmond MB, Polk RE. Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals. Clin Infect Dis 2005; 41(4): 435-440 (Pubitemid 41099634)
24. Lepper PM, Grusa E, Reichl H, Högel J, Trautmann M. Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2002; 46(9): 2920-2925 (Pubitemid 34898673)
25. Paterson Dl, Muto Ca, Gross P, Ndirangu Mw, Kuznetsov D, Harrison Lh. Does the "Defined Daily Dose" (DDD) Adequately Measure Antibiotic Utilization in Hospitalized Patients in Tertiary Medical Centers? Abstr Intersci Conf Antimicrob Agents Chemother Intersci Conf Antimicrob Agents Chemother 2002; 42.
26. Atntibiotics and antimicrobial therapy. Avalaible from: http://www. antibiotic.ru/index.php?newlang=eng
27. Davey P, Brown E, Fenelon L, Finch R, Gould I, Hartman G, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev CD003543; 2005.